R A Willemsen - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Gene Therapy|February 4, 1999

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesM E Weijtens, R A Willemsen, E H Hart, et al.

International Journal of Cancer|July 3, 1998

Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory moleculesM E Weijtens, R A Willemsen, B A van Krimpen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996

Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacityM E Weijtens, R A Willemsen, D Valerio, et al.

Gene Therapy|March 16, 2002

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytesR A Willemsen, R Debets, E Hart, et al.

Gene Therapy|September 12, 2000

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCRR A Willemsen, M E Weijtens, C Ronteltap, et al.

Cancer Gene Therapy|November 12, 2005

Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancerC H J Lamers, R A Willemsen, P van Elzakker, et al.

Gene Therapy|August 18, 2001

Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteinsM Engelstädter, C J Buchholz, M Bobkova, et al.

Journal of Biological Regulators and Homeostatic Agents|October 9, 2004

Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytesC H J Lamers, S Sleijfer, R A Willemsen, et al.

International Journal of Cancer|August 30, 2000

An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cellsA Hombach, C Schneider, D Sent, et al.

International Immunology|July 31, 2007

Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML)W Yang, E L Beaudoin, L Lu, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Gene Therapy|February 4, 1999

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesM E Weijtens, R A Willemsen, E H Hart, et al.

International Journal of Cancer|July 3, 1998

Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory moleculesM E Weijtens, R A Willemsen, B A van Krimpen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996

Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacityM E Weijtens, R A Willemsen, D Valerio, et al.

Gene Therapy|March 16, 2002

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytesR A Willemsen, R Debets, E Hart, et al.

Gene Therapy|September 12, 2000

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCRR A Willemsen, M E Weijtens, C Ronteltap, et al.

Cancer Gene Therapy|November 12, 2005

Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancerC H J Lamers, R A Willemsen, P van Elzakker, et al.

Gene Therapy|August 18, 2001

Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteinsM Engelstädter, C J Buchholz, M Bobkova, et al.

Journal of Biological Regulators and Homeostatic Agents|October 9, 2004

Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytesC H J Lamers, S Sleijfer, R A Willemsen, et al.

International Journal of Cancer|August 30, 2000

An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cellsA Hombach, C Schneider, D Sent, et al.

International Immunology|July 31, 2007

Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML)W Yang, E L Beaudoin, L Lu, et al.

Pageof 2